StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories clinicalTrials.gov — New Abbott Clinical Studies Started

NIH ClinicalTrials.gov API v2

QuarterlyAnnual
Latest, Q3 2026
12
Period ended Sep 30, 2026
Change on a year earlier
+20.0%
10 in Q3 2025
History
51 quarters
Since Q1 2014
Sources
1
NIH ClinicalTrials.gov Registry — Abbott Laboratories

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedClinicalTrials.gov — New Abbott Clinical Studies StartedYear on yearSource
Q3 2026Sep 30, 202612+20.0%NIH ClinicalTrials.gov Registry — Abbott Laboratories ↗
Q2 2026Jun 30, 20264-76.5%NIH ClinicalTrials.gov Registry — Abbott Laboratories ↗
Q1 2026Mar 31, 20269+28.6%NIH ClinicalTrials.gov Registry — Abbott Laboratories ↗
Q4 2025Dec 31, 202511-21.4%NIH ClinicalTrials.gov Registry — Abbott Laboratories ↗
Q3 2025Sep 30, 202510-23.1%NIH ClinicalTrials.gov Registry — Abbott Laboratories ↗
Q2 2025Jun 30, 202517+112.5%NIH ClinicalTrials.gov Registry — Abbott Laboratories ↗
Q1 2025Mar 31, 20257-50.0%NIH ClinicalTrials.gov Registry — Abbott Laboratories ↗
Q4 2024Dec 31, 202414+40.0%NIH ClinicalTrials.gov Registry — Abbott Laboratories ↗
Q3 2024Sep 30, 202413+18.2%NIH ClinicalTrials.gov Registry — Abbott Laboratories ↗
Q2 2024Jun 30, 202480.0%NIH ClinicalTrials.gov Registry — Abbott Laboratories ↗
Q1 2024Mar 31, 2024140.0%NIH ClinicalTrials.gov Registry — Abbott Laboratories ↗
Q4 2023Dec 31, 202310-9.1%NIH ClinicalTrials.gov Registry — Abbott Laboratories ↗
Q3 2023Sep 30, 202311-26.7%NIH ClinicalTrials.gov Registry — Abbott Laboratories ↗
Q2 2023Jun 30, 20238-38.5%NIH ClinicalTrials.gov Registry — Abbott Laboratories ↗
Q1 2023Mar 31, 202314-30.0%NIH ClinicalTrials.gov Registry — Abbott Laboratories ↗
Q4 2022Dec 31, 202211-21.4%NIH ClinicalTrials.gov Registry — Abbott Laboratories ↗

Cite this data

StockData. (2026). Abbott Laboratories ClinicalTrials.gov — New Abbott Clinical Studies Started, quarterly Q1 2014–Q3 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ext-ct-started

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.